Morgan Stanley Sees $180B Patent Cliff, $380B Deal Capacity Fueling Biopharma M&A
Amgen Inc.'s (NASDAQ:AMGN) High Institutional Ownership Speaks for Itself as Stock Continues to Impress, up 6.4% Over Last Week
Amgen (AMGN) Rises Higher Than Market: Key Facts
Express News | Amgen Inc - Issues Statement on Irs Notice Related to Horizon Acquisition
Express News | Live On CNBC, Kevin Simpson Announces Bought More Amgen
These Are the Weight Loss Drug Stocks With the Most Upside - SA Sentiment Survey
UBS Downgrades Amgen(AMGN.US) to Hold Rating, Raises Target Price to $337
UBS analyst Trung Huynh downgrades $Amgen(AMGN.US)$ to a hold rating, and adjusts the target price from $200 to $337.According to TipRanks data, the analyst has a success rate of 75.5% and a total
Express News | Amgen Shares Hit Record-High, Last up 1.1%
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Express News | Amgen Inc : UBS Raises Target Price to $337 From $307
This Weight Loss Stock Is the Best Alternative to Eli Lilly, Novo - SA Sentiment
Check Out What Whales Are Doing With AMGN
Investors with a lot of money to spend have taken a bullish stance on Amgen (NASDAQ:AMGN).And retail traders should know.We noticed this today when the trades showed up on publicly available options
Amgen Is Maintained at Equal-Weight by Morgan Stanley
Amgen Is Maintained at Equal-Weight by Morgan
Amgen Price Target Cut to $303.00/Share From $310.00 by Morgan Stanley
Amgen Price Target Cut to $303.00/Share From $310.00 by Morgan
Amgen Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/11/2024 -5.77% Morgan Stanley $310 → $303 Maintains Equal-Weight 06/27/2024 5.73% Argus Research $300 →
Amgen Inc.'s (NASDAQ:AMGN) Large Institutional Owners Must Be Happy as Stock Continues to Impress, up 4.0% Over the Past Week
Key Insights Significantly high institutional ownership implies Amgen's stock price is sensitive to their trading actions The top 25 shareholders own 49% of the company Insiders have sold
Amgen on Track for Record High Close -- Data Talk
Amgen Inc. (AMGN) is currently at $326.65, up $4.98 or 1.55% --Would be new all-time high (Based on available data back to June 17, 1983) --Would be the first record close since Feb. 1, 2024, when
Express News | Amgen Inc : Morgan Stanley Cuts Target Price to $303 From $310
Morgan Stanley Adjusts Price Target on Amgen to $303 From $310
Amgen (AMGN) has an average rating of outperform and price targets ranging from $170 to $380, according to analysts by Capital IQ.Price: 319.42, Change: -2.25, Percent Change: -0.70
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity
No Data